Review of blood pressure control rates and outcomes

George Bakris, Pantelis Sarafidis, Rajiv Agarwal, Luis Ruilope

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Despite the high prevalence of hypertension and documented benefits of blood pressure (BP) control, >40% of patients with hypertension are not controlled. A majority of uncontrolled hypertensive patients receive two or more antihypertensive drugs. The current review examined the relationship between antihypertensive combination drug therapy, achievement of goal BP, and cardiovascular (CV) outcomes. Articles were selected from a PubMed search using a prespecified search strategy. Randomized, controlled clinical trials of adult human subjects published in English between January 1991 and January 2013 were included. From 2319 identified articles, 28 met inclusion criteria and contained a total of 226,877 subjects. There were seven placebo-controlled studies and 21 treatment comparator and combination therapy studies. The studies included in this review reported a positive association between the degree of BP lowering, number of medications, and CV outcomes. As combination therapy became available, it was increasingly utilized in clinical trials and enabled an increased proportion of patients to achieve a prespecified BP target. Adverse events with monotherapy and combination therapy were as anticipated for the specific classes of antihypertensive therapy. Although many patients reach BP goal, combination antihypertensive therapy is often needed to reach BP goal. Effective BP lowering has been shown to result in improvements in CV outcomes.

Original languageEnglish
Pages (from-to)127-141
Number of pages15
JournalJournal of the American Society of Hypertension
Volume8
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Blood Pressure
Antihypertensive Agents
Therapeutics
Hypertension
Combination Drug Therapy
PubMed
Randomized Controlled Trials
Placebos
Clinical Trials

Keywords

  • cardiovascular diseases
  • drug therapy
  • Hypertension
  • morbidity
  • mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Review of blood pressure control rates and outcomes. / Bakris, George; Sarafidis, Pantelis; Agarwal, Rajiv; Ruilope, Luis.

In: Journal of the American Society of Hypertension, Vol. 8, No. 2, 02.2014, p. 127-141.

Research output: Contribution to journalArticle

Bakris, George ; Sarafidis, Pantelis ; Agarwal, Rajiv ; Ruilope, Luis. / Review of blood pressure control rates and outcomes. In: Journal of the American Society of Hypertension. 2014 ; Vol. 8, No. 2. pp. 127-141.
@article{4d062520083e465bb0a8d80f55664fd9,
title = "Review of blood pressure control rates and outcomes",
abstract = "Despite the high prevalence of hypertension and documented benefits of blood pressure (BP) control, >40{\%} of patients with hypertension are not controlled. A majority of uncontrolled hypertensive patients receive two or more antihypertensive drugs. The current review examined the relationship between antihypertensive combination drug therapy, achievement of goal BP, and cardiovascular (CV) outcomes. Articles were selected from a PubMed search using a prespecified search strategy. Randomized, controlled clinical trials of adult human subjects published in English between January 1991 and January 2013 were included. From 2319 identified articles, 28 met inclusion criteria and contained a total of 226,877 subjects. There were seven placebo-controlled studies and 21 treatment comparator and combination therapy studies. The studies included in this review reported a positive association between the degree of BP lowering, number of medications, and CV outcomes. As combination therapy became available, it was increasingly utilized in clinical trials and enabled an increased proportion of patients to achieve a prespecified BP target. Adverse events with monotherapy and combination therapy were as anticipated for the specific classes of antihypertensive therapy. Although many patients reach BP goal, combination antihypertensive therapy is often needed to reach BP goal. Effective BP lowering has been shown to result in improvements in CV outcomes.",
keywords = "cardiovascular diseases, drug therapy, Hypertension, morbidity, mortality",
author = "George Bakris and Pantelis Sarafidis and Rajiv Agarwal and Luis Ruilope",
year = "2014",
month = "2",
doi = "10.1016/j.jash.2013.07.009",
language = "English",
volume = "8",
pages = "127--141",
journal = "Journal of the American Society of Hypertension",
issn = "1933-1711",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Review of blood pressure control rates and outcomes

AU - Bakris, George

AU - Sarafidis, Pantelis

AU - Agarwal, Rajiv

AU - Ruilope, Luis

PY - 2014/2

Y1 - 2014/2

N2 - Despite the high prevalence of hypertension and documented benefits of blood pressure (BP) control, >40% of patients with hypertension are not controlled. A majority of uncontrolled hypertensive patients receive two or more antihypertensive drugs. The current review examined the relationship between antihypertensive combination drug therapy, achievement of goal BP, and cardiovascular (CV) outcomes. Articles were selected from a PubMed search using a prespecified search strategy. Randomized, controlled clinical trials of adult human subjects published in English between January 1991 and January 2013 were included. From 2319 identified articles, 28 met inclusion criteria and contained a total of 226,877 subjects. There were seven placebo-controlled studies and 21 treatment comparator and combination therapy studies. The studies included in this review reported a positive association between the degree of BP lowering, number of medications, and CV outcomes. As combination therapy became available, it was increasingly utilized in clinical trials and enabled an increased proportion of patients to achieve a prespecified BP target. Adverse events with monotherapy and combination therapy were as anticipated for the specific classes of antihypertensive therapy. Although many patients reach BP goal, combination antihypertensive therapy is often needed to reach BP goal. Effective BP lowering has been shown to result in improvements in CV outcomes.

AB - Despite the high prevalence of hypertension and documented benefits of blood pressure (BP) control, >40% of patients with hypertension are not controlled. A majority of uncontrolled hypertensive patients receive two or more antihypertensive drugs. The current review examined the relationship between antihypertensive combination drug therapy, achievement of goal BP, and cardiovascular (CV) outcomes. Articles were selected from a PubMed search using a prespecified search strategy. Randomized, controlled clinical trials of adult human subjects published in English between January 1991 and January 2013 were included. From 2319 identified articles, 28 met inclusion criteria and contained a total of 226,877 subjects. There were seven placebo-controlled studies and 21 treatment comparator and combination therapy studies. The studies included in this review reported a positive association between the degree of BP lowering, number of medications, and CV outcomes. As combination therapy became available, it was increasingly utilized in clinical trials and enabled an increased proportion of patients to achieve a prespecified BP target. Adverse events with monotherapy and combination therapy were as anticipated for the specific classes of antihypertensive therapy. Although many patients reach BP goal, combination antihypertensive therapy is often needed to reach BP goal. Effective BP lowering has been shown to result in improvements in CV outcomes.

KW - cardiovascular diseases

KW - drug therapy

KW - Hypertension

KW - morbidity

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=84894030074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894030074&partnerID=8YFLogxK

U2 - 10.1016/j.jash.2013.07.009

DO - 10.1016/j.jash.2013.07.009

M3 - Article

VL - 8

SP - 127

EP - 141

JO - Journal of the American Society of Hypertension

JF - Journal of the American Society of Hypertension

SN - 1933-1711

IS - 2

ER -